TY - JOUR AU - Di Fiore, P. P. AU - Pierce, J. H. AU - Kraus, M. H. AU - Segatto, O. AU - King, C. R. AU - Aaronson, S. A. PY - 1987 DA - 1987// TI - erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells JO - Science VL - 237 UR - https://doi.org/10.1126/science.2885917 DO - 10.1126/science.2885917 ID - Di Fiore1987 ER - TY - JOUR AU - Kauraniemi, P. AU - Kallioniemi, A. PY - 2006 DA - 2006// TI - Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer JO - Endocr Relat Cancer VL - 13 UR - https://doi.org/10.1677/erc.1.01147 DO - 10.1677/erc.1.01147 ID - Kauraniemi2006 ER - TY - JOUR AU - Rajkumar, T. AU - Gullick, W. J. PY - 1994 DA - 1994// TI - The type I growth factor receptors in human breast cancer JO - Breast Cancer Res Treat VL - 29 UR - https://doi.org/10.1007/BF00666177 DO - 10.1007/BF00666177 ID - Rajkumar1994 ER - TY - JOUR AU - Hanna, W. AU - Kahn, H. J. AU - Trudeau, M. PY - 1999 DA - 1999// TI - Evaluation of HER-2/neu (erbB-2) status in breast cancer: from bench to bedside JO - Mod Pathol VL - 12 ID - Hanna1999 ER - TY - JOUR AU - Zhang, D. AU - Salto-Tellez, M. AU - Do, E. AU - Putti, T. C. AU - Koay, E. S. PY - 2003 DA - 2003// TI - Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays JO - Hum Pathol VL - 34 UR - https://doi.org/10.1053/hupa.2003.60 DO - 10.1053/hupa.2003.60 ID - Zhang2003 ER - TY - JOUR AU - De Potter, C. R. AU - Schelfhout, A. M. PY - 1995 DA - 1995// TI - The neu-protein and breast cancer JO - Virchows Arch VL - 426 UR - https://doi.org/10.1007/BF00192631 DO - 10.1007/BF00192631 ID - De Potter1995 ER - TY - JOUR AU - Slamon, D. J. AU - Clark, G. M. AU - Wong, S. G. AU - Levin, W. J. AU - Ullrich, A. AU - McGuire, W. L. PY - 1987 DA - 1987// TI - Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene JO - Science VL - 235 UR - https://doi.org/10.1126/science.3798106 DO - 10.1126/science.3798106 ID - Slamon1987 ER - TY - JOUR AU - Plosker, G. L. AU - Keam, S. J. PY - 2006 DA - 2006// TI - Trastuzumab: a review of its use in the management of HER2-positive metastatic and early-stage breast cancer JO - Drugs VL - 66 UR - https://doi.org/10.2165/00003495-200666040-00005 DO - 10.2165/00003495-200666040-00005 ID - Plosker2006 ER - TY - JOUR AU - Baselga, J. AU - Tripathy, D. AU - Mendelsohn, J. AU - Baughman, S. AU - Benz, C. C. AU - Dantis, L. AU - Sklarin, N. T. AU - Seidman, A. D. AU - Hudis, C. A. AU - Moore, J. PY - 1999 DA - 1999// TI - Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer JO - Semin Oncol VL - 26 ID - Baselga1999 ER - TY - JOUR AU - Leyland-Jones, B. PY - 2002 DA - 2002// TI - Trastuzumab: hopes and realities JO - Lancet Oncol VL - 3 UR - https://doi.org/10.1016/S1470-2045(02)00676-9 DO - 10.1016/S1470-2045(02)00676-9 ID - Leyland-Jones2002 ER - TY - JOUR AU - Tripathy, D. AU - Slamon, D. J. AU - Cobleigh, M. AU - Arnold, A. AU - Saleh, M. AU - Mortimer, J. E. AU - Murphy, M. AU - Stewart, S. J. PY - 2004 DA - 2004// TI - Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.06.557 DO - 10.1200/JCO.2004.06.557 ID - Tripathy2004 ER - TY - JOUR AU - Tuma, R. S. PY - 2005 DA - 2005// TI - Trastuzumab trials steal show at ASCO meeting JO - J Natl Cancer Inst VL - 97 UR - https://doi.org/10.1093/jnci/97.12.870 DO - 10.1093/jnci/97.12.870 ID - Tuma2005 ER - TY - JOUR AU - Press, M. F. AU - Hung, G. AU - Godolphin, W. AU - Slamon, D. J. PY - 1994 DA - 1994// TI - Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression JO - Cancer Res VL - 54 ID - Press1994 ER - TY - JOUR AU - Pauletti, G. AU - Dandekar, S. AU - Rong, H. AU - Ramos, L. AU - Peng, H. AU - Seshadri, R. AU - Slamon, D. J. PY - 2000 DA - 2000// TI - Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situhybridization and immunohistochemistry JO - J Clin Oncol VL - 18 ID - Pauletti2000 ER - TY - JOUR AU - Tapia, C. AU - Schraml, P. AU - Simon, R. AU - Al-Kuraya, K. S. AU - Maurer, R. AU - Mirlacher, M. AU - Novotny, H. AU - Spichtin, H. AU - Mihatsch, M. J. AU - Sauter, G. PY - 2004 DA - 2004// TI - HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsies JO - Int J Oncol VL - 25 ID - Tapia2004 ER - TY - JOUR AU - Mass, R. D. AU - Press, M. F. AU - Anderson, S. AU - Cobleigh, M. A. AU - Vogel, C. L. AU - Dybdal, N. AU - Leiberman, G. AU - Slamon, D. J. PY - 2005 DA - 2005// TI - Evaluation of clinical outcomes according to HER2 detection by fluorescence in situhybridization in women with metastatic breast cancer treated with trastuzumab JO - Clin Breast Cancer VL - 6 UR - https://doi.org/10.3816/CBC.2005.n.026 DO - 10.3816/CBC.2005.n.026 ID - Mass2005 ER - TY - JOUR AU - Press, M. F. AU - Sauter, G. AU - Bernstein, L. AU - Villalobos, I. E. AU - Mirlacher, M. AU - Zhou, J. Y. AU - Wardeh, R. AU - Li, Y. T. AU - Guzman, R. AU - Ma, Y. PY - 2005 DA - 2005// TI - Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-05-0636 DO - 10.1158/1078-0432.CCR-05-0636 ID - Press2005 ER - TY - JOUR AU - Gokhale, S. AU - Gatalica, Z. AU - Mohammad, A. AU - Rampy, A. I. AU - Velagaleti Gopalrao, V. N. PY - 2004 DA - 2004// TI - FISH for HER-2/neu in breast cancer: standardization makes the difference! JO - Indian J Cancer VL - 41 ID - Gokhale2004 ER - TY - JOUR AU - Gong, Y. AU - Booser, D. J. AU - Sneige, N. PY - 2005 DA - 2005// TI - Comparison of HER-2 status determined by fluorescence in situhybridization in primary and metastatic breast carcinoma JO - Cancer VL - 103 UR - https://doi.org/10.1002/cncr.20987 DO - 10.1002/cncr.20987 ID - Gong2005 ER - TY - JOUR AU - Gancberg, D. AU - Di Leo, A. AU - Cardoso, F. AU - Rouas, G. AU - Pedrocchi, M. AU - Paesmans, M. AU - Verhest, A. AU - Bernard-Marty, C. AU - Piccart, M. J. AU - Larsimont, D. PY - 2002 DA - 2002// TI - Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites JO - Ann Oncol VL - 13 UR - https://doi.org/10.1093/annonc/mdf252 DO - 10.1093/annonc/mdf252 ID - Gancberg2002 ER - TY - JOUR AU - Regitnig, P. AU - Schippinger, W. AU - Lindbauer, M. AU - Samonigg, H. AU - Lax, S. F. PY - 2004 DA - 2004// TI - Change of HER-2/neu status in a subset of distant metastases from breast carcinomas JO - J Pathol VL - 203 UR - https://doi.org/10.1002/path.1592 DO - 10.1002/path.1592 ID - Regitnig2004 ER - TY - JOUR AU - Bozzetti, C. AU - Personeni, N. AU - Nizzoli, R. AU - Guazzi, A. AU - Flora, M. AU - Bassano, C. AU - Negri, F. AU - Martella, E. AU - Naldi, N. AU - Franciosi, V. PY - 2003 DA - 2003// TI - HER-2/neu amplification by fluorescence in situhybridization in cytologic samples from distant metastatic sites of breast carcinoma JO - Cancer VL - 99 UR - https://doi.org/10.1002/cncr.11731 DO - 10.1002/cncr.11731 ID - Bozzetti2003 ER - TY - JOUR AU - Tanner, M. AU - Jarvinen, P. AU - Isola, J. PY - 2001 DA - 2001// TI - Amplification of HER-2/neu and topoisomerase IIα in primary and metastatic breast cancer JO - Cancer Res VL - 61 ID - Tanner2001 ER - TY - JOUR AU - Elston, C. W. AU - Ellis, I. O. PY - 1991 DA - 1991// TI - Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up JO - Histopathology VL - 19 UR - https://doi.org/10.1111/j.1365-2559.1991.tb00229.x DO - 10.1111/j.1365-2559.1991.tb00229.x ID - Elston1991 ER - TY - JOUR AU - Kononen, J. AU - Bubendorf, L. AU - Kallioniemi, A. AU - Barlund, M. AU - Schraml, P. AU - Leighton, S. AU - Torhorst, J. AU - Mihatsch, M. J. AU - Sauter, G. AU - Kallioniemi, O. P. PY - 1998 DA - 1998// TI - Tissue microarrays for high-throughput molecular profiling of tumor specimens JO - Nat Med VL - 4 UR - https://doi.org/10.1038/nm0798-844 DO - 10.1038/nm0798-844 ID - Kononen1998 ER - TY - JOUR AU - Goldhirsch, A. AU - Glick, J. H. AU - Gelber, R. D. AU - Coates, A. S. AU - Thurlimann, B. AU - Senn, H. J. PY - 2005 DA - 2005// TI - Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005 JO - Ann Oncol VL - 16 UR - https://doi.org/10.1093/annonc/mdi326 DO - 10.1093/annonc/mdi326 ID - Goldhirsch2005 ER - TY - JOUR AU - Ross, J. S. AU - Fletcher, J. A. AU - Bloom, K. J. AU - Linette, G. P. AU - Stec, J. AU - Symmans, W. F. AU - Pusztai, L. AU - Hortobagyi, G. N. PY - 2004 DA - 2004// TI - Targeted therapy in breast cancer: the HER-2/neu gene and protein JO - Mol Cell Proteomics VL - 3 UR - https://doi.org/10.1074/mcp.R400001-MCP200 DO - 10.1074/mcp.R400001-MCP200 ID - Ross2004 ER - TY - JOUR AU - Di Leo, A. AU - Dowsett, M. AU - Horten, B. AU - Penault-Llorca, F. PY - 2002 DA - 2002// TI - Current status of HER2 testing JO - Oncology VL - 63 UR - https://doi.org/10.1159/000066204 DO - 10.1159/000066204 ID - Di Leo2002 ER - TY - JOUR AU - Cobleigh, M. A. AU - Vogel, C. L. AU - Tripathy, D. AU - Robert, N. J. AU - Scholl, S. AU - Fehrenbacher, L. AU - Wolter, J. M. AU - Paton, V. AU - Shak, S. AU - Lieberman, G. PY - 1999 DA - 1999// TI - Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease JO - J Clin Oncol VL - 17 ID - Cobleigh1999 ER - TY - JOUR AU - Simon, R. AU - Nocito, A. AU - Hubscher, T. AU - Bucher, C. AU - Torhorst, J. AU - Schraml, P. AU - Bubendorf, L. AU - Mihatsch, M. M. AU - Moch, H. AU - Wilber, K. PY - 2001 DA - 2001// TI - Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer JO - J Natl Cancer Inst VL - 93 UR - https://doi.org/10.1093/jnci/93.15.1141 DO - 10.1093/jnci/93.15.1141 ID - Simon2001 ER - TY - JOUR AU - Bilous, M. AU - Dowsett, M. AU - Hanna, W. AU - Isola, J. AU - Lebeau, A. AU - Moreno, A. AU - Penault-Llorca, F. AU - Ruschoff, J. AU - Tomasic, G. AU - van de Vijver, M. PY - 2003 DA - 2003// TI - Current perspectives on HER2 testing: a review of national testing guidelines JO - Mod Pathol VL - 16 UR - https://doi.org/10.1097/01.MP.0000052102.90815.82 DO - 10.1097/01.MP.0000052102.90815.82 ID - Bilous2003 ER - TY - JOUR AU - Elkin, E. B. AU - Weinstein, M. C. AU - Winer, E. P. AU - Kuntz, K. M. AU - Schnitt, S. J. AU - Weeks, J. C. PY - 2004 DA - 2004// TI - HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.04.158 DO - 10.1200/JCO.2004.04.158 ID - Elkin2004 ER - TY - JOUR AU - Gong, Y. AU - Gilcrease, M. AU - Sneige, N. PY - 2005 DA - 2005// TI - Reliability of chromogenic in situ hybridization for detecting HER-2 gene status in breast cancer: comparison with fluorescence in situhybridization and assessment of interobserver reproducibility JO - Mod Pathol VL - 18 UR - https://doi.org/10.1038/modpathol.3800432 DO - 10.1038/modpathol.3800432 ID - Gong2005 ER - TY - JOUR AU - Persons, D. L. AU - Tubbs, R. R. AU - Cooley, L. D. AU - Dewald, G. W. AU - Dowling, P. K. AU - Du, E. AU - Mascarello, J. T. AU - Rao, K. W. AU - Wilson, K. S. AU - Wolff, D. J. PY - 2006 DA - 2006// TI - HER-2 fluorescence in situ hybridization: results from the survey program of the College of American Pathologists JO - Arch Pathol Lab Med VL - 130 ID - Persons2006 ER - TY - JOUR AU - Kunitomo, K. AU - Inoue, S. AU - Ichihara, F. AU - Kono, K. AU - Fujii, H. AU - Matsumoto, Y. AU - Ooi, A. PY - 2004 DA - 2004// TI - A case of metastatic breast cancer with outgrowth of HER2-negative cells after eradication of HER2-positive cells by humanized anti-HER2 monoclonal antibody (trastuzumab) combined with docetaxel JO - Hum Pathol VL - 35 UR - https://doi.org/10.1016/j.humpath.2003.05.003 DO - 10.1016/j.humpath.2003.05.003 ID - Kunitomo2004 ER - TY - JOUR AU - Sekido, Y. AU - Umemura, S. AU - Takekoshi, S. AU - Suzuki, Y. AU - Tokuda, Y. AU - Tajima, T. AU - Osamura, R. Y. PY - 2003 DA - 2003// TI - Heterogeneous gene alterations in primary breast cancer contribute to discordance between primary and asynchronous metastatic/recurrent sites: HER2 gene amplification and p53 mutation JO - Int J Oncol VL - 22 ID - Sekido2003 ER - TY - JOUR AU - Shin, S. J. AU - Hyjek, E. AU - Early, E. AU - Knowles, D. M. PY - 2006 DA - 2006// TI - Intratumoral heterogeneity of her-2/neu in invasive mammary carcinomas using fluorescence in-situ hybridization and tissue microarray JO - Int J Surg Pathol VL - 14 UR - https://doi.org/10.1177/1066896906293055 DO - 10.1177/1066896906293055 ID - Shin2006 ER - TY - JOUR AU - Moriki, T. AU - Takahashi, T. AU - Ueta, S. AU - Mitani, M. AU - Ichien, M. PY - 2004 DA - 2004// TI - Hormone receptor status and HER2/neu overexpression determined by automated immunostainer on routinely fixed cytologic specimens from breast carcinoma: correlation with histologic sections determinations and diagnostic pitfalls JO - Diagn Cytopathol VL - 30 UR - https://doi.org/10.1002/dc.20007 DO - 10.1002/dc.20007 ID - Moriki2004 ER - TY - JOUR AU - Sauter, G. AU - Feichter, G. AU - Torhorst, J. AU - Moch, H. AU - Novotna, H. AU - Wagner, U. AU - Durmuller, U. AU - Waldman, F. M. PY - 1996 DA - 1996// TI - Fluorescence in situhybridization for detecting erbB-2 amplification in breast tumor fine needle aspiration biopsies JO - Acta Cytol VL - 40 UR - https://doi.org/10.1159/000333683 DO - 10.1159/000333683 ID - Sauter1996 ER - TY - JOUR AU - Nizzoli, R. AU - Guazzi, A. AU - Naldi, N. AU - Fraciosi, V. AU - Bozzetti, C. PY - 2005 DA - 2005// TI - HER-2/neu evaluation by fluorescence in situ hybridization on destained cytologic smears from primary and metastatic breast cancer JO - Acta Cytol VL - 49 UR - https://doi.org/10.1159/000326091 DO - 10.1159/000326091 ID - Nizzoli2005 ER - TY - JOUR AU - Bozzetti, C. AU - Nizzoli, R. AU - Guazzi, A. AU - Flora, M. AU - Bassano, C. AU - Crafa, P. AU - Naldi, N. AU - Cascinu, S. PY - 2002 DA - 2002// TI - HER-2/neu amplification detected by fluorescence in situhybridization in fine needle aspirates from primary breast cancer JO - Ann Oncol VL - 13 UR - https://doi.org/10.1093/annonc/mdf217 DO - 10.1093/annonc/mdf217 ID - Bozzetti2002 ER - TY - JOUR AU - Gu, M. AU - Ghafari, S. AU - Zhao, M. PY - 2005 DA - 2005// TI - Fluorescence in situhybridization for HER-2/neu amplification of breast carcinoma in archival fine needle aspiration biopsy specimens JO - Acta Cytol VL - 49 UR - https://doi.org/10.1159/000326190 DO - 10.1159/000326190 ID - Gu2005 ER - TY - JOUR AU - Fitzgibbons, P. L. AU - Page, D. L. AU - Weaver, D. AU - Thor, A. D. AU - Allred, D. C. AU - Clark, G. M. AU - Ruby, S. G. AU - O'Malley, F. AU - Simpson, J. F. AU - Connolly, J. L. PY - 2000 DA - 2000// TI - Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999 JO - Arch Pathol Lab Med VL - 124 ID - Fitzgibbons2000 ER - TY - JOUR AU - Ross, J. S. AU - Fletcher, J. A. AU - Linette, G. P. AU - Stec, J. AU - Clark, E. AU - Ayers, M. AU - Symmans, W. F. AU - Pusztai, L. AU - Bloom, K. J. PY - 2003 DA - 2003// TI - The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy JO - Oncologist VL - 8 UR - https://doi.org/10.1634/theoncologist.8-4-307 DO - 10.1634/theoncologist.8-4-307 ID - Ross2003 ER -